Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Guangzhou, China.
Markey Cancer Center, the University of Kentucky, College of Medicine, Lexington, Kentucky.
Clin Cancer Res. 2019 Jun 15;25(12):3673-3688. doi: 10.1158/1078-0432.CCR-18-2739. Epub 2019 Mar 18.
The overall biological roles and clinical significance of most long noncoding RNAs (lncRNA) in chemosensitivity are not fully understood. We investigated the biological function, mechanism, and clinical significance of lncRNA NR_034085, which we termed miRNA processing-related lncRNA (MPRL), in tongue squamous cell carcinoma (TSCC).
LncRNA expression in TSCC cell lines with cisplatin treatment was measured by lncRNA microarray and confirmed in TSCC tissues. The functional roles of MPRL were demonstrated by a series of and experiments. The miRNA profiles, RNA pull-down, RNA immunoprecipitation, serial deletion analysis, and luciferase analyses were used to investigate the potential mechanisms of MPRL.
We found that MPRL expression was significantly upregulated in TSCC cell lines treated with cisplatin and transactivated by E2F1. MPRL controlled mitochondrial fission and cisplatin sensitivity through miR-483-5p. In exploring the underlying interaction between MPRL and miR-483-5p, we identified that cytoplasmic MPRL directly binds to pre-miR-483 within the loop region and blocks pre-miR-483 recognition and cleavage by TRBP-DICER-complex, thereby inhibiting miR-483-5p generation and upregulating miR-483-5p downstream target-FIS1 expression. Furthermore, overexpression or knockdown MPRL altered tumor apoptosis and growth in mouse xenografts. Importantly, we found that high expression of MPRL and pre-miR-483, and low expression of miR-483-5p were significantly associated with neoadjuvant chemosensitivity and better TSCC patients' prognosis.
We propose a model in which lncRNAs impair microprocessor recognition and are efficient of pre-miRNA cropping. In addition, our study reveals a novel regulatory network for mitochondrial fission and chemosensitivity and new biomarkers for prediction of neoadjuvant chemosensitivity in TSCC.These findings uncover a novel mechanism by which lncRNA determines mitochondrial fission and cisplatin chemosensitivity by inhibition of pre-miRNA processing and provide for the first time the rationale for lncRNA and miRNA biogenesis for predicting chemosensitivity and patient clinical prognosis.
大多数长非编码 RNA(lncRNA)在化疗敏感性中的整体生物学作用和临床意义尚未完全阐明。我们研究了 lncRNA NR_034085 的生物学功能、机制和临床意义,我们将其称为 miRNA 加工相关 lncRNA(MPRL),在舌鳞状细胞癌(TSCC)中。
通过 lncRNA 微阵列测量顺铂处理的 TSCC 细胞系中的 lncRNA 表达,并在 TSCC 组织中进行验证。通过一系列和实验证明了 MPRL 的功能作用。使用 miRNA 谱、RNA 下拉、RNA 免疫沉淀、串联缺失分析和荧光素酶分析来研究 MPRL 的潜在机制。
我们发现 MPRL 表达在顺铂处理的 TSCC 细胞系中显着上调,并被 E2F1 转录激活。MPRL 通过 miR-483-5p 控制线粒体裂变和顺铂敏感性。在探索 MPRL 和 miR-483-5p 之间的潜在相互作用时,我们发现细胞质 MPRL 直接结合在环区中的 pre-miR-483 上,并阻止 TRBP-DICER 复合物识别和切割 pre-miR-483,从而抑制 miR-483-5p 的产生并上调 miR-483-5p 的下游靶标-FIS1 表达。此外,过表达或敲低 MPRL 改变了小鼠异种移植中的肿瘤凋亡和生长。重要的是,我们发现 MPRL 和 pre-miR-483 的高表达以及 miR-483-5p 的低表达与新辅助化疗敏感性和 TSCC 患者的良好预后显著相关。
我们提出了一个模型,其中 lncRNA 损害微处理器的识别,并且是 pre-miRNA 切割的有效方法。此外,我们的研究揭示了线粒体裂变和化疗敏感性的新调控网络,以及预测 TSCC 新辅助化疗敏感性的新生物标志物。这些发现揭示了 lncRNA 通过抑制 pre-miRNA 加工来决定线粒体裂变和顺铂化疗敏感性的新机制,并首次为 lncRNA 和 miRNA 生物发生提供了用于预测化疗敏感性和患者临床预后的依据。